Building on our recent finding that endogenous lamin A and progerin can be measured by MS [7], we demonstrate here that immune-based approaches could be replaced with a LC-MS/MS-based method for the quantification of lamin A and post-translationally farnesylated progerin in cells from HGPS patients. The gene discussed is LMNA; the disease is Hutchinson-Gilford progeria syndrome.